Toggle navigation
Home
Search
Services
Blog
Contact
About
Topic 313 Phase I;Rnai Cancer Therapeutics Using Nanotechnology; Hhsn2612013000
Unger, Gretchen
Genesegues, Inc., Chaska, MN, United States
Search 11 grants from Gretchen Unger
Search grants from Genesegues, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mechanisms of CNS node of Ranvier formation
Carcinogenic Interactions of Radiation and Chemicals
Aging Brain: DTI, Subcortical Ischemia and Behavioral
San Fernando Valley Partnership Against Substance Abuse
Mass Spectrometric Sequencing of Proteins
Recently added grants:
Impacts of a Novel law-enforcement delivered intervention on drug user health
Project 5: Tumor Suppressor and Tumor Maintenance Genes
Core A: Administration
The role of neuroactive steroids in stress, drug craving and drug use in cocaine use disorders
Core B: Gene Modulation with RNAi and CRISPER
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
261201300030C-0-0-1
Application #
8762476
Study Section
Project Start
2013-09-20
Project End
2014-06-19
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$200,000
Indirect Cost
Institution
Name
Genesegues, Inc.
Department
Type
DUNS #
095972415
City
Chaska
State
MN
Country
United States
Zip Code
55318
Comments
Be the first to comment on Gretchen Unger's grant